D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Marcus Corp
MCS
$862M
| $896K | ﹤0.01% |
62,852
-24,299
| -28% | -$344K |
|
|
WIRE
3027
CALL
DELISTED
Encore Wire Corp
WIRE
| $893K | ﹤0.01% |
3,400
-12,800
| -79% | -$2.9M |
|
|
SCHW
3028
Charles Schwab
SCHW
$181B
| $893K | ﹤0.01% |
12,345
-247,932
| -95% | -$16.3M |
|
3029
PUT
CRISPR Therapeutics
CRSP
$5.54B
| $893K | ﹤0.01% |
13,100
-73,200
| -85% | -$5.24M |
|
3030
Smith & Wesson
SWBI
$598M
| $892K | ﹤0.01% |
51,379
| – | – |
|
3031
Invesco S&P MidCap 400 Pure Value ETF
RFV
$332M
| $891K | ﹤0.01% |
+7,469
| New | +$842K |
|
3032
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.29B
| $890K | ﹤0.01% |
43,500
-18,700
| -30% | -$377K |
|
3033
iShares JPMorgan EM Corporate Bond ETF
CEMB
$429M
| $890K | ﹤0.01% |
20,000
+14,500
| +264% | +$640K |
|
3034
PUT
InMode
INMD
$837M
| $886K | ﹤0.01% |
41,000
+22,600
| +123% | +$505K |
|
3035
Allient
ALNT
$1.69B
| $885K | ﹤0.01% |
24,813
-789
| -3% | -$23.6K |
|
3036
Heartland Express
HTLD
$922M
| $884K | ﹤0.01% |
74,053
+50,656
| +217% | +$644K |
|
3037
CALL
Sweetgreen
SG
$814M
| $884K | ﹤0.01% |
35,000
-133,500
| -79% | -$1.94M |
|
3038
Simplify Health Care ETF
PINK
$367M
| $881K | ﹤0.01% |
+28,481
| New | +$835K |
|
|
GRMN
3039
Garmin
GRMN
$53.1B
| $879K | ﹤0.01% |
5,905
+925
| +19% | +$122K |
|
|
PLAO
3040
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
| $876K | ﹤0.01% |
77,604
| – | – |
|
|
HIMX
3041
Himax Technologies
HIMX
$2.38B
| $876K | ﹤0.01% |
163,728
+144,716
| +761% | +$827K |
|
3042
Newmark Group
NMRK
$2.51B
| $875K | ﹤0.01% |
78,937
-745,573
| -90% | -$7.8M |
|
3043
Allogene Therapeutics
ALLO
$598M
| $875K | ﹤0.01% |
195,778
+120,138
| +159% | +$501K |
|
3044
CALL
SiriusXM
SIRI
$9.35B
| $873K | ﹤0.01% |
+22,500
| New | +$1.07M |
|
|
BLUE
3045
DELISTED
bluebird bio
BLUE
| $872K | ﹤0.01% |
+34,063
| New | +$873K |
|
|
AIEV
3046
DELISTED
Thunder Power Holdings, Inc. Common Stock
AIEV
| $870K | ﹤0.01% |
+80,000
| New | +$871K |
|
3047
Independent Bank Corp
IBCP
$804M
| $870K | ﹤0.01% |
34,300
-8,636
| -20% | -$215K |
|
3048
CALL
Oneok
OKE
$58.8B
| $866K | ﹤0.01% |
10,800
+2,500
| +30% | +$182K |
|
|
HCP
3049
PUT
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $862K | ﹤0.01% |
32,000
| – | – |
|
3050
PUT
ProFrac Holding
ACDC
$922M
| $862K | ﹤0.01% |
+103,100
| New | +$792K |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.